Center for Devices and Radiological Health
Generated by GPT-5-miniExpansion Funnel Raw 71 → Dedup 0 → NER 0 → Enqueued 0
| Center for Devices and Radiological Health | |
|---|---|
| Name | Center for Devices and Radiological Health |
| Native name | CDRH |
| Formation | 1976 |
| Headquarters | White Oak, Maryland |
| Parent organization | Food and Drug Administration |
Center for Devices and Radiological Health is the United States federal regulatory body within the Food and Drug Administration responsible for assuring the safety, effectiveness, and quality of medical devices and radiological products. It evaluates premarket applications, enforces postmarket surveillance, conducts standards-setting research, and coordinates emergency responses involving diagnostic, therapeutic, and radiation-emitting products. CDRH interacts with a wide range of stakeholders, including manufacturers, clinical investigators, hospitals, payers, and international regulators.
History
The center evolved from regulatory precedents set by the Food, Drug, and Cosmetic Act and the Medical Device Amendments of 1976, aligning with initiatives like the Kefauver Harris Amendment and the Safe Medical Devices Act of 1990. Early milestones intersected with policy debates involving the National Institutes of Health, the Centers for Disease Control and Prevention, and congressional committees such as the House Committee on Energy and Commerce and the Senate Committee on Health, Education, Labor, and Pensions. Subsequent legislative and administrative events including the Food and Drug Administration Amendments Act of 2007 and responses to incidents like the 2009 H1N1 influenza pandemic and the 2014 Ebola virus epidemic in West Africa shaped the center’s modern mandate. International harmonization efforts linked its work with bodies such as the International Medical Device Regulators Forum, the World Health Organization, and the European Medicines Agency.
Organization and Leadership
The center operates within the Food and Drug Administration structure under leadership appointed or confirmed through processes involving the United States Department of Health and Human Services and oversight by the United States Congress. Executive directors and senior officials have engaged with stakeholders including the American Medical Association, the American Academy of Pediatrics, and the Association for the Advancement of Medical Instrumentation. Organizational units collaborate with federal partners such as the National Institutes of Health, the Centers for Medicare & Medicaid Services, and the Occupational Safety and Health Administration. Leadership has testified before committees including the House Committee on Oversight and Government Reform and worked with international counterparts from agencies like Health Canada and the Therapeutic Goods Administration.
Regulatory Authorities and Programs
The center administers authorities derived from statutes like the Food, Drug, and Cosmetic Act and implements programs aligned with initiatives from the World Health Organization and the Organisation for Economic Co-operation and Development. Key programs interface with standards organizations including International Organization for Standardization and ASTM International, and coordinate with accreditation bodies such as The Joint Commission and the College of American Pathologists. The center's regulatory toolbox resonates with post-market obligations enforced through mechanisms referenced in the Safe Medical Devices Act of 1990 and policies influenced by advisory committees including panels from the Advisory Committee on Medical Devices and collaborations with the National Academies of Sciences, Engineering, and Medicine.
Premarket Review and Approval Processes
Premarket pathways administered by the center include 510(k) clearances, Premarket Approval applications, and De Novo classifications, processes shaped by precedent from case law and guidance documents influenced by entities like the Federal Food, Drug, and Cosmetic Act adjudications and reports from the Government Accountability Office. Clinical trial oversight occurs in coordination with institutional review boards such as those at the Mayo Clinic, Johns Hopkins Hospital, and Massachusetts General Hospital, and interfaces with sponsors including multinational firms like Johnson & Johnson, Medtronic, Philips, and Siemens Healthineers. The center’s review standards reference international guidance from the International Medical Device Regulators Forum and technical norms from International Electrotechnical Commission committees.
Postmarket Surveillance and Compliance
Postmarket activities encompass adverse event reporting systems, recalls, inspections, and corrective actions interacting with stakeholders such as the Association of American Medical Colleges, professional societies like the American College of Surgeons, and hospital networks including Kaiser Permanente and Cleveland Clinic. The center coordinates enforcement with the Department of Justice in civil and criminal matters, and engages forensic analysis from laboratories like those at the Centers for Disease Control and Prevention and research universities such as Stanford University and University of California, San Francisco. Surveillance initiatives have been informed by investigations into devices referenced in high-profile litigation involving companies such as Ethicon and Boston Scientific.
Research, Standards, and Innovation
The center sponsors internal research and external collaborations with academic partners including Harvard Medical School, University of Pennsylvania, and Duke University, and works with standard-setting organizations such as ISO and IEEE to develop performance criteria for devices and radiological equipment. Innovation programs connect to accelerators and initiatives like Biomedical Advanced Research and Development Authority, the Small Business Innovation Research program, and consortia including the Medical Device Innovation Consortium. The center’s work supports translational science efforts at institutions such as the Whitehead Institute and industry-university partnerships with firms like GE Healthcare and Abbott Laboratories.
Public Health Initiatives and Emergency Response
The center plays a central role in emergency preparedness and response alongside the Centers for Disease Control and Prevention, the Department of Homeland Security, and the Federal Emergency Management Agency. During public health emergencies, it issues emergency use authorizations and coordinates supply-chain actions with partners like McKesson Corporation and Cardinal Health, while collaborating with international agencies such as the World Health Organization and European Commission on global responses. Public health outreach includes engagements with professional organizations like the American Nurses Association and patient advocacy groups including American Heart Association and March of Dimes to improve access, safety, and innovation in medical device use.